Reckitt Benckiser Healthcare (UK) Limited Patent applications |
Patent application number | Title | Published |
20140039057 | Compositions - An ingestible particulate composition including at least one compound selected from the group consisting of 2,4-dichlorobenzyl alcohol, amylmetacresol, cetylpyridinium chloride, hexitidine, hexylresorcinol, flurbiprofen, lidocaine, benzocaine, ibuprofen, paracetamol, pectin, menthol, and benzydamine and one or more bioadhesive materials. Resulting particulate compositions have excellent flow characteristics, dust suppression, organoleptic properties and stability. They are highly suitable for administration direction into a patient's mouth, and ingested to alleviate the symptoms of a sore throat. | 02-06-2014 |
20140037727 | Tablet Of Paracetamol Containing An Encapsulated Flavorant - A medicament tablet containing paracetamol (acetaminophen) as the (or an) active ingredient, and an encapsulated flavorant. The tablet may be swallowed in tablet form or may be dissolved or dispersed in water to form a palatable drink. | 02-06-2014 |
20120121655 | Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate - The present invention relates to a solid, ingestible composition comprising: a) an alginate; b) a bicarbonate; and c) a carbonate wherein the composition is in the form of a chewable core, a process for preparing said composition, and its use in the treatment of reflux oesophagitis, gastritis, dyspepsia or peptic ulceration or for use as a sustained releasing or targeted delivery composition. | 05-17-2012 |
20110201685 | Compositions - An ingestible particulate composition comprises: a) at least one compound selected from the group consisting of 2,4-dichlorobenzyl alcohol, amylmetacresol, cetylpyridinium chloride, hexitidine, hexylresorcinol, flurbiprofen, lidocaine, benzocaine, ibuprofen, paracetamol, pectin, menthol, and benzydamine; and b) one or more bioadhesive materials. Resulting particulate compositions have excellent flow characteristics, dust suppression, organoleptic properties and stability. They are highly suitable for administration direction into a patient's mouth, and ingested to alleviate the symptoms of a sore throat. | 08-18-2011 |
20100292265 | Pack Of Medicinal Tablets - A water- and oxygen-occlusive pack is described. The pack encloses an inert atmosphere containing medicinal tablets, wherein the tablets contain buprenorphine or a salt or ester thereof. | 11-18-2010 |
20100234412 | Buprenorphine Derivatives and Uses Thereof - Ester derivatives of the phenolic hydroxyl group of buprenorphine can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential. | 09-16-2010 |
20100168147 | Medicinal Compositions Comprising Buprenorphine And Naloxone - There is provided a composition for the treatment of pain in human patients wherein said composition comprises buprenorphine to naloxone in a ratio by weight of from 2.1:1 to 8:1, the amount of buprenorphine and naloxone being suitable to provide analgesia, the composition being in a transdermal or transmucosal dosage form. Also provided are an associated method and use. | 07-01-2010 |
20100152222 | Medicinal Compositions Comprising Buprenorphine And Nalmefene - An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount nalmefene such that the ratio by weight of buprenorphine to nalmefene delivered to or reaching the plasma of a patient is in the range 22.6:1 to 40:1. The analgesic action of the buprenorphine is potentiated by the low dose of nalmefene. Also provided are a method of treatment of pain and the use of nalmefene and buprenorphine for the manufacture of a medicament. | 06-17-2010 |
20100147864 | PACKAGING WITH SEALING LID AND METHODS FOR FILLING THE PACKAGE - A packaging for a pharmaceutical product comprising a body portion ( | 06-17-2010 |
20100120812 | Medicinal Compositions Comprising Buprenorphine And Naltrexone - An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naltrexone such that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range 100:1 to 5000:1. The analgesic action of the buprenorphine is potentiated by the low dose of naltrexone. Also provided are a method of treatment of pain and the use of buprenorphine and naltrexone for the manufacture of a medicament. | 05-13-2010 |
20090166244 | PACK - A tablet housing comprises two generally rigid leaves hinged together, each leaf having (1) recesses or apertures to align with and receive the projecting tablet cells of a blister pack of tablets, and (2) closure means. The housing may be opened in order to access tablets and closed in order to protect and retain tablets. | 07-02-2009 |
20090152156 | DEVICE FOR DISPENSING FROM A BLISTER PACK - A pack for medicinal tablets has two parts hinged together, each part having pockets containing tablets. The pockets may be displaced to expel the tablets through a foil sheet. | 06-18-2009 |
20090142392 | Composition Comprising a NSAID and Paracetamol - A process for producing a granular composition comprising a plurality of solidified melt granules including a non-steroidal anti-inflammatory drug (NSAID) and paracetamol (acetaminophen), the process comprising the steps of: (a) forming a melt mixture by mixing a molten NSAID free acid and paracetamol, optionally with one or more excipients; and (b) forming the melt mixture into solidified melt granules. The granules are useable in compositions for treating pain and/or inflammation and/or fever. | 06-04-2009 |